Is praluent produced in china the u's or both countries?

See the DrugPatentWatch profile for praluent

Short answer: There isn’t public information saying Praluent is produced in China. Praluent (alirocumab) is developed by Regeneron and Sanofi and is manufactured at multiple global facilities. The exact manufacturing sites are not typically disclosed in public product labeling, but production is generally described as multi-site and international (primarily serving the US and European markets).

If you need the precise site information for a specific lot or regulatory reason, you could check the current labeling (FDA/EMA) or contact Regeneron/Sanofi directly for the most up-to-date manufacturing details.